CRO mass spectroscopy services market seen growing to $3.32 billion by 2030
The contract research organization mass spectroscopy services market is projected to grow from $1.81 billion in 2025 to $3.32 billion by 2030, driven by pharmaceutical and biotech R&D, precision medicine work and outsourcing of advanced analytics. North America was the largest regional market in 2025.
Why it matters: - CRO mass spectroscopy services are becoming a core outsourced tool for drug development, clinical research, environmental monitoring and other scientific work. - The market’s projected growth signals rising demand for faster, more precise analytical support across pharma, biotech and adjacent testing segments. - A longer runway for outsourced analytical work could benefit CROs that offer high-resolution mass spectrometry, proteomics and metabolomics capabilities.
What happened: - The market is forecast to rise from $1.81 billion in 2025 to $2.05 billion in 2026. - The report projects the market will reach $3.32 billion by 2030, implying a 12.8% CAGR. - The Business Research Company published the outlook in its Contract Research Organization Global Market Report 2026. - North America was the largest regional market in 2025.
The details: - The market’s recent growth has been supported by pharmaceutical and biopharmaceutical R&D, greater reliance on CRO analytical services and more biomarker discovery activity. - Expanded use of mass spectrometry in drug metabolism studies has also supported demand. - Environmental and food safety testing is another growth driver. - The report says growth through 2030 will be fueled by investment in precision medicine research, increasing biologics and cell therapy complexity, rising multi-omics needs and expanding clinical proteomics applications. - Outsourcing of advanced analytical workflows is also expected to keep increasing. - Emerging trends include higher demand for high-resolution mass spectrometry, more outsourced proteomics and metabolomics services, growth in bioanalytical method development, stronger use of advanced data analytics for spectral interpretation and a greater focus on regulatory-compliant testing. - CRO mass spectroscopy services use mass spectrometry to identify, quantify and structurally characterize chemical compounds, biomolecules and complex mixtures. - The services support drug development, clinical research, environmental monitoring and other scientific investigations. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables.
Between the lines: - The forecast reflects a broader shift toward specialized outsourced science as drug pipelines become more complex and compliance requirements tighten. - Pharmaceutical and biotechnology growth is feeding the market, but the demand pattern also suggests a wider customer base beyond drugmakers, including testing and monitoring applications. - The report’s emphasis on analytics, multi-omics and high-resolution tools points to a market where technical depth may matter as much as scale.
What’s next: - More outsourcing of advanced analytical workflows is expected as precision medicine, biologics and cell therapy programs expand. - CROs with stronger bioanalytical development and data interpretation capabilities are likely to be better positioned for future demand. - More information is available in the full report and a free sample.
The bottom line: - CRO mass spectroscopy services are on track for steady double-digit growth as drug development gets more complex and more analytical work moves outside in-house labs.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
STEM News Today
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.